Cell of Origin and Microenvironment Contribution for NF1-Associated Dermal Neurofibromas

Al-Hajj, 2004, Self-renewal and solid tumor stem cells, Oncogene, 23, 7274, 10.1038/sj.onc.1207947 Biernaskie, 2006, Isolation of skin-derived precursors (SKPs) and differentiation and enrichment of their Schwann cell progeny, Nat. Protocols, 1, 2803, 10.1038/nprot.2006.422 Biernaskie, 2007, Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury, J. Neurosci., 27, 9545, 10.1523/JNEUROSCI.1930-07.2007 Cichowski, 2001, NF1 tumor suppressor gene function: narrowing the GAP, Cell, 104, 593, 10.1016/S0092-8674(01)00245-8 Cichowski, 1999, Mouse models of tumor development in neurofibromatosis type 1, Science, 286, 2172, 10.1126/science.286.5447.2172 Dugoff, 1996, Neurofibromatosis type 1 and pregnancy, Am. J. Med. Genet., 66, 7, 10.1002/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R Fernandes, 2004, A dermal niche for multipotent adult skin-derived precursor cells, Nat. Cell Biol., 6, 1082, 10.1038/ncb1181 Fernandes, 2006, Analysis of the neurogenic potential of multipotent skin-derived precursors, Exp. Neurol., 201, 32, 10.1016/j.expneurol.2006.03.018 Fernandes, 2008, Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential, Philos. Trans. R. Soc. Lond. B Biol. Sci., 363, 185, 10.1098/rstb.2006.2020 Ferner, 2007, Neurofibromatosis 1, Eur. J. Hum. Genet., 15, 131, 10.1038/sj.ejhg.5201676 Gao, 2008, Cancer stem cells: the lessons from pre-cancerous stem cells, J. Cell. Mol. Med., 12, 67, 10.1111/j.1582-4934.2007.00170.x Gardner, 2007 Gray, 1993, Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice, Cancer Res., 53, 577 Hayashi, 2002, Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse, Dev. Biol., 244, 305, 10.1006/dbio.2002.0597 Huson, 1988, Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales, Brain, 111, 1355, 10.1093/brain/111.6.1355 Joseph, 2008, The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells, Cancer Cell, 13, 129, 10.1016/j.ccr.2008.01.003 Jung-Testas, 1996, Demonstration of progesterone receptors in rat Schwann cells, J. Steroid Biochem. Mol. Biol., 58, 77, 10.1016/0960-0760(96)00009-X Kwon, 2008, Pten haploinsufficiency accelerates formation of high-grade astrocytomas, Cancer Res., 68, 3286, 10.1158/0008-5472.CAN-07-6867 Lakkis, 2000, Neurofibromatosis type 1. I. General overview, J. Neurosci. Res., 62, 755, 10.1002/1097-4547(20001215)62:6<755::AID-JNR1>3.0.CO;2-W Le, 2007, Tumor microenvironment and neurofibromatosis type I: connecting the GAPs, Oncogene, 26, 4609, 10.1038/sj.onc.1210261 McKenzie, 2006, Skin-derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system, J. Neurosci., 26, 6651, 10.1523/JNEUROSCI.1007-06.2006 McLaughlin, 2003, Progesterone receptor expression in neurofibromas, Cancer Res., 63, 752 Miller, 2005, Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications, Biochim. Biophys. Acta, 1756, 25 Movaghar, 2008, Transdifferentiation of bone marrow stromal cells into Schwann cell phenotype using progesterone as inducer, Brain Res., 1208, 17, 10.1016/j.brainres.2008.02.071 Nowell, 1960, Chromosome studies on normal and leukemic human leukocytes, J. Natl. Cancer Inst., 25, 85 Nussbaum, 2007, Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response, FASEB J., 21, 1345, 10.1096/fj.06-6769com Overdiek, 2008, Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone, Pediatr. Res., 64, 40, 10.1203/PDR.0b013e31817445b8 Prophet, E., Mills, B., Arrington, J., and Sobin, L., eds. (1992). Laboratory Methods in Histotechnology (Washington, D.C.: American Registry of Pathology). Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Riccardi, 1981, Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells, Birth Defects Orig. Artic. Ser., 17, 129 Roth, 2008, Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin, Dev. Dyn., 237, 513, 10.1002/dvdy.21430 Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 Soriano, 1999, Generalized lacZ expression with the ROSA26 Cre reporter strain, Nat. Genet., 21, 70, 10.1038/5007 Stemmer-Rachamimov, 2004, Comparative pathology of nerve sheath tumors in mouse models and humans, Cancer Res., 64, 3718, 10.1158/0008-5472.CAN-03-4079 Stenback, 1981, Initiation and promotion at different ages and doses in 2200 mice. I. Methods, and the apparent persistence of initiated cells, Br. J. Cancer, 44, 1, 10.1038/bjc.1981.141 Stindl, 2008, Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells, Med. Hypotheses, 71, 126, 10.1016/j.mehy.2008.01.010 Szudek, 2000, Associations of clinical features in neurofibromatosis 1 (NF1), Genet. Epidemiol., 19, 429, 10.1002/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N Toma, 2001, Isolation of multipotent adult stem cells from the dermis of mammalian skin, Nat. Cell Biol., 3, 778, 10.1038/ncb0901-778 Toma, 2005, Isolation and characterization of multipotent skin-derived precursors from human skin, Stem Cells, 23, 727, 10.1634/stemcells.2004-0134 Trovo-Marqui, 2006, Neurofibromin: a general outlook, Clin. Genet., 70, 1, 10.1111/j.1399-0004.2006.00639.x Vogel, 1999, Mouse tumor model for neurofibromatosis type 1, Science, 286, 2176, 10.1126/science.286.5447.2176 Ward, 2005, Neurofibromatosis 1: from lab bench to clinic, Pediatr. Neurol., 32, 221, 10.1016/j.pediatrneurol.2004.11.002 Wong, 2004, The BCR-ABL story: bench to bedside and back, Annu. Rev. Immunol., 22, 247, 10.1146/annurev.immunol.22.012703.104753 Wu, 2008, Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells, Cancer Cell, 13, 105, 10.1016/j.ccr.2007.12.027 Yang, 2003, Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/− mast cells, J. Clin. Invest., 112, 1851, 10.1172/JCI19195 Yang, 2006, Nf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling, Hum. Mol. Genet., 15, 2421, 10.1093/hmg/ddl165 Yang, 2008, Nf1-dependent tumors require a microenvironment containing Nf1+/−- and c-kit-dependent bone marrow, Cell, 135, 437, 10.1016/j.cell.2008.08.041 Zheng, 2008, Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation, Cancer Cell, 13, 117, 10.1016/j.ccr.2008.01.002 Zhu, 2001, Neurofibromin, a tumor suppressor in the nervous system, Exp. Cell Res., 264, 19, 10.1006/excr.2000.5138 Zhu, 2002, Neurofibromas in NF1: Schwann cell origin and role of tumor environment, Science, 296, 920, 10.1126/science.1068452